Phreesia Inc.

Background

Company Name	Phreesia Inc.
Stock Symbol	PHR
Class Period	May 08, 2025 to March 30, 2026
Lead Plaintiff Motion Deadline	July 13, 2026

Submit Your Information

If you suffered a loss on your Phreesia Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before May 08, 2025?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments

Background

On March 30, 2026, after market hours, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, citing a combination of macroeconomic factors including “worsening visibility” and weaker pharmaceutical marketing commitments within its Network Solutions segment.

On this news, Phreesia’s stock price fell $3.03, or 26.6%, to close at $8.38 per share on March 31, 2026, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants created the false impression that they possessed reliable information pertaining to the Company’s long-term growth outlook through expansion of its key revenue platforms and remained confident in its revenue growth projections for fiscal year 2027, while also minimizing risks from slowing growth in its Network Solutions segment. In truth, Phreesia’s portrayal of its pharmaceutical marketing commitments as a durable growth driver of its Network Solutions segment was uncertain thereby putting the 2027 revenue target at risk.

Submit Your Information